Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
11
Apr |
Genes Identified That May Help In Ovarian Cancer Diagnosis And PrognosisCategory: Ovarian Cancer | Leave a Comment |
Scientists from Duke University Medical Center have determined that genes acting as molecular “on/off” switches can define clinically relevant molecular subtypes of ovarian cancer, providing ideal potential targets for use in clinical prognostic and diagnostic testing. These bimodal genes can define tumor subtypes that have different overall prognoses and respond to different therapeutic regimens…
|
21
Sep |
New Imaging Technique Highlights Cancer During SurgeryCategory: Ovarian Cancer | Leave a Comment |
Ovarian cancer is one of the most frequent forms of cancer that affect women. As tumors can initially grow unchecked in the abdomen without causing any major symptoms, patients are usually diagnosed at an advanced stage and have to undergo surgery plus chemotherapy. During the operation, surgeons attempt to remove all tumor deposits as this leads to improved patient prognosis…
|
15
Sep |
Potential To Spot Hard-To-Detect Ovarian Cancer Using New Hybrid Imaging DeviceCategory: Ovarian Cancer | Leave a Comment |
By combining three previously unrelated imaging tools into one new device, a team of researchers from the University of Connecticut and the University of Southern California has proposed a new way to diagnose early-stage ovarian cancer in high-risk women through minimally invasive surgery. The new technique may be better than the current standard procedure of preemptively removing the ovaries…
|
13
Sep |
New Combined-Tool Imaging May Spot Hard To Detect Ovarian CancerCategory: Ovarian Cancer | Leave a Comment |
Using only minimally invasive surgery, a device that combines three previously unrelated imaging tools may help diagnose hard to detect early-stage ovarian cancer in high-risk women, thanks to the efforts of researchers from the University of Connecticut and the University of Southern California in the US…
|
25
May |
OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test And Clinical AssessmentCategory: Ovarian Cancer | Leave a Comment |
A paper published in the June issue of Obstetrics & Gynecology demonstrated that adding OVA1 to a physician’s preoperative assessment of a woman’s ovarian mass would identify more ovarian cancers than a physician’s preoperative assessment alone…
|
14
May |
OVA1 Blood Test Detects Ovarian Cancer More Accurately Than Medically Accepted CA 125 Method For Evaluating Women With Ovarian MassCategory: Ovarian Cancer | Leave a Comment |
A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology (ACOG) guidelines for determining the likelihood that an ovarian mass is cancerous prior to surgery would accurately identify more women with ovarian cancer if the OVA1 blood test were used in place of the currently recommen…
|
14
May |
OVA1 Blood Test Detects Ovarian Cancer More Accurately Than Medically Accepted CA 125 Method For Evaluating Women With Ovarian MassCategory: Ovarian Cancer | Leave a Comment |
A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology (ACOG) guidelines for determining the likelihood that an ovarian mass is cancerous prior to surgery would accurately identify more women with ovarian cancer if the OVA1 blood test were used in place of the currently recommen…
|
14
May |
OVA1 Blood Test Detects Ovarian Cancer More Accurately Than Medically Accepted CA 125 Method For Evaluating Women With Ovarian MassCategory: Ovarian Cancer | Leave a Comment |
A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology (ACOG) guidelines for determining the likelihood that an ovarian mass is cancerous prior to surgery would accurately identify more women with ovarian cancer if the OVA1 blood test were used in place of the currently recommen…
|
11
Mar |
Mabcure Study Results On A New Ovarian Cancer Diagnostic Blood Test Being Presented At The Annual Meeting Of The Society Of Gynecological OncologistsCategory: Ovarian Cancer | Leave a Comment |
Biotechnology company MabCure, Inc. (OTCBB: MBCI) is presenting the results of its recently completed study on the diagnosis of ovarian cancer utilizing its proprietary monoclonal antibodies at the annual meeting of the Society of Gynecological Oncologists (SGO)…
|
21
Dec |
Cancer Sniffed Out By Electronic NoseCategory: Ovarian Cancer | Leave a Comment |
Gyorgy Horvath from the University of Gothenburg, Sweden, and researchers from the University of Gavle and KTH Royal Institute of Technology have been able to confirm in tests that ovarian cancer tissue and healthy tissue smell different. The results were published recently in the journal Future Oncology…